-
ICPT Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Intercept Pharmaceuticals (ICPT)
Company Profile
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 103.66 mm | 103.66 mm | 103.66 mm | 103.66 mm | 103.66 mm | 103.66 mm |
Cash burn (monthly) | 11.24 mm | 1.38 mm | 1.54 mm | 5.19 mm | (no burn) | 5.25 mm |
Cash used (since last report) | 194.30 mm | 23.81 mm | 26.63 mm | 89.75 mm | n/a | 90.82 mm |
Cash remaining | -90.64 mm | 79.85 mm | 77.03 mm | 13.90 mm | n/a | 12.84 mm |
Runway (months of cash) | -8.1 | 58.0 | 50.0 | 2.7 | n/a | 2.4 |
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 4.00 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Genextra S.p.A. | 4.00 mm | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Nov 23 | Bradbury Daniel | Common Stock | Sale back to company | Dispose D | No | No | 19 | 8,111 | 154.11 k | 0 |
8 Nov 23 | Bradbury Daniel | Common Stock | Dispose U | Yes | No | 19 | 7,812 | 148.43 k | 0 | |
8 Nov 23 | Bradbury Daniel | Common Stock | Dispose U | No | No | 19 | 23,548 | 447.41 k | 0 | |
8 Nov 23 | Bradbury Daniel | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 72.74 | 2,966 | 215.75 k | 0 |
8 Nov 23 | Bradbury Daniel | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 82.25 | 2,174 | 178.81 k | 0 |
8 Nov 23 | Bradbury Daniel | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 85.12 | 2,748 | 233.91 k | 0 |
8 Nov 23 | Bradbury Daniel | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 122.01 | 2,036 | 248.41 k | 0 |
8 Nov 23 | Bradbury Daniel | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 145.22 | 3,196 | 464.12 k | 0 |
8 Nov 23 | Bradbury Daniel | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 9.17 | 12,547 | 115.06 k | 0 |
8 Nov 23 | Bradbury Daniel | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 16.82 | 12,790 | 215.13 k | 0 |